Gita Kwatra, PharmD, MBA, co-founder and CEO of the Glioblastoma Foundation, explains what happens to tumor tissue after brain surgery and how patients can ask their care team for genomic testing.
|Articles|December 30, 2016
Fran Drescher: Living "Old School" to Prevent Cancer
Author(s)Fran Drescher
Fran Drescher, actress, author and 16-year cancer survivor, spoke at CURE's GBM Heroes event.
Advertisement
Fran Drescher, actress, author and 16-year cancer survivor, spoke at CURE's GBM Heroes event.
Drescher's movement, Cancer Schmancer, focuses on finding and eliminating the causes of cancer before the disease even develops. To do this, she says, people must be aware of inflammation and environmental factors that affect health, while turning back to an "old school" way of living.
Advertisement
Related to this article
Ohio State hematologist Dr. Kerry Rogers says chemotherapy and newer targeted drugs both work well, and the right choice depends on the patient.
Gita Kwatra, PharmD, MBA, co-founder and CEO of the Glioblastoma Foundation, discusses why every patient with glioblastoma should have their tumor profiled, and what patients can ask their care team.
A breast surgeon explains why patients should raise lymphedema with their care team at the start of treatment, and how early detection can make it reversible.
A woman with stage 4 pancreatic cancer shares how a once-daily RAS inhibitor changed her energy, routine and time with family.
Brad Dugai and Russ Reed discuss symptom relief, skin-related side effects and challenges accessing Rasonque, a treatment for pancreatic cancer.
A nurse practitioner discusses how an app provides information on cancer treatments, potential side effects and preparing for medical appointments.
Final KEYNOTE-564 data show Keytruda after kidney cancer surgery lowered the risk of death by 30%. Dr. Toni Choueiri explains what it means for patients.
Advertisement
Advertisement